Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients, and the private equity / venture capital community. For 30 years, we have offered objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.
July 10, 2020 BOSTON, MA; SAN FRANCISCO, CA; NEW YORK, NY; LONDON, UK – We couldn’t be more thrilled as a firm to announce recent promotions in our Boston, San Francisco, New York and London offices across multiple levels including the promotion of Sean O’Malley to Partner in San Francisco. Scott Gilbert, Partner in theread more
July 10, 2020 – Putnam is honored to be a member of the MIT Solve community for the fourth year in a row! Putnam teams convened virtually today to contribute to the initial screening of proposals by assessing and scoring submissions. All told, our team will have reviewed and provided feedback on 150 submissions, helpingread more
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.